Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: In this session 116 PD of the New York Annual Meeting the panel discusses factors which led to the development of alternative risk transfer transactions in the property and casualty markets, and review techniques used to transfer and trade insurance risks within the capital markets. From the Record of the Society of Actuaries, Vol. 24, No. 3.